Overactive Bladder Treatment market in terms of revenue was estimated to be worth $3.5 billion in 2022 and is poised to reach ...

Antimuscarinic drugs are the first-line treatment for overactive bladder. However, traditional formulations are associated with a number of adverse effects, most notably dry mouth. A study ...

For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

The standard treatments for overactive bladder include lifestyle changes, bladder training, pelvic floor muscle training and anticholinergic (anti-muscarinic) drugs. Additional treatments for some ...

Medication remains a common first-line treatment ... Some individuals find complementary therapies helpful in managing bladder control issues. Acupuncture shows promise in reducing overactive bladder ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

The symptoms may be temporary or chronic. Temporary overactive bladder symptoms are often a result of medication side effects or urinary tract infections (UTIs). These symptoms typically resolve ...

MEDICATIONS taken by thousands of Brits for to treat an overactive bladder have been linked to dementia in a new study. Some forms of the medication have been found to raise the risk of dementia ...

Drugs to treat overactive bladder don't work very well, according to a recent CR Best Buy Drugs analysis. Studies have found that only a small proportion of people get full relief of their ...

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...

A new study has “substantially” linked dementia and some common medications prescribed to older Brits for a completely different disorder particularly if given to people over the age of 55 ...